Protalix BioTherapeutics
PLX
#8627
Rank
NZ$0.31 B
Marketcap
NZ$3.89
Share price
13.04%
Change (1 day)
-10.95%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): NZ$12.95 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$61.84 Million. In 2024 the company made an earning of NZ$8.66 Million a decrease over its 2023 earnings that were of NZ$19.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$12.95 M49.59%
2024 NZ$8.66 M-55.62%
2023 NZ$19.51 M-199.05%
2022 -NZ$19.71 Million-40.38%
2021 -NZ$33.06 Million-732.31%
2020 NZ$5.22 M-130.53%
2019 -NZ$17.12 Million189.85%
2018 -NZ$5.91 Million-95.29%
2017 -NZ$0.13 Billion308.12%
2016 -NZ$30.74 Million-32.37%
2015 -NZ$45.45 Million10.11%
2014 -NZ$41.28 Million-7.59%
2013 -NZ$44.67 Million
2011 -NZ$51.72 Million-19.39%
2010 -NZ$64.17 Million20.87%
2009 -NZ$53.09 Million32.26%
2008 -NZ$40.14 Million-5.46%
2007 -NZ$42.46 Million
2004 -NZ$0.28 Million12.35%
2003 -NZ$0.25 Million-11.1%
2002 -NZ$0.28 Million-57.03%
2001 -NZ$0.65 Million1.03%
2000 -NZ$0.64 Million-53.22%
1999 -NZ$1.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$19.67 B 158,795.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$0.96 B 7,718.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$8.27 M-33.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.94 B 23,656.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel